Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis

    Retinal optical coherence tomography has been identified as biomarker for disease progression in relapsing-remitting multiple sclerosis (RRMS), while the dynamics of retinal atrophy in progressive MS are less ...

    Julia Krämer, Carolin Balloff, Margit Weise, Valeria Koska in Nature Communications (2024)

  2. Article

    Open Access

    Correction: Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder

    Stacey L. Clardy, Sean J. Pittock, Orhan Aktas, ** Nakahara in Neurology and Therapy (2024)

  3. Article

    Open Access

    Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

    Tania Kümpfel, Katrin Giglhuber, Orhan Aktas, Ilya Ayzenberg in Journal of Neurology (2024)

  4. Article

    Open Access

    Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder

    Anti-aquaporin-4 antibody-positive (AQP4-Ab+) neuromyelitis optica spectrum disorder (NMOSD) is a complement-mediated autoimmune disease in which unpredictable and relapsing attacks on the central nervous syst...

    Stacey L. Clardy, Sean J. Pittock, Orhan Aktas, ** Nakahara in Neurology and Therapy (2024)

  5. Article

    Open Access

    Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

    This manuscript presents practical recommendations for managing acute attacks and implementing preventive immunotherapies for neuromyelitis optica spectrum disorders (NMOSD), a rare autoimmune disease that cau...

    Tania Kümpfel, Katrin Giglhuber, Orhan Aktas, Ilya Ayzenberg in Journal of Neurology (2024)

  6. Article

    Open Access

    Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis

    The term ‘neuromyelitis optica spectrum disorders’ (NMOSD) is used as an umbrella term that refers to aquaporin-4 immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica (NMO) and its formes frustes and to a nu...

    Sven Jarius, Orhan Aktas, Ilya Ayzenberg, Judith Bellmann-Strobl in Journal of Neurology (2023)

  7. Article

    Thinking outside the box: non-canonical targets in multiple sclerosis

    Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system that causes demyelination, axonal degeneration and astrogliosis, resulting in progressive neurological disability. Fuelled by...

    Laura Bierhansl, Hans-Peter Hartung, Orhan Aktas in Nature Reviews Drug Discovery (2022)

  8. Article

    Open Access

    Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients

    Comprehensive data on the cerebrospinal fluid (CSF) profile in patients with COVID-19 and neurological involvement from large-scale multicenter studies are missing so far.

    Sven Jarius, Florence Pache, Peter Körtvelyessy in Journal of Neuroinflammation (2022)

  9. Article

    Open Access

    Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper)

    Die Multiple Sklerose ist eine komplexe, autoimmun vermittelte Erkrankung des zentralen Nervensystems, charakterisiert durch inflammatorische Demyelinisierung sowie axonalen/neuronalen Schaden. Die Zulassung v...

    Univ.-Prof. Dr. Heinz Wiendl, Prof. Dr. Ralf Gold, Thomas Berger in Der Nervenarzt (2021)

  10. No Access

    Article

    Von der Neuromyelitis optica zur Neuromyelitis-optica-Spektrum-Erkrankung: vom klinischen Syndrom zur Klassifikation

    Die Neuromyelitis-optica-Spektrum-Erkrankung („neuromyelitis optica spectrum disorder“, NMOSD) – abgeleitet von NMO oder „Devic-Syndrom“ – wird seit Entdeckung des Anti-Aquaporin-4-Serumantikörpers (AQP4-IgG) ...

    Orhan Aktas, Prof. Dr. Tania Kümpfel in Der Nervenarzt (2021)

  11. Article

    Open Access

    Occipital repetitive transcranial magnetic stimulation does not affect multifocal visual evoked potentials

    To identify mechanisms of cortical plasticity of the visual cortex and to quantify their significance, sensitive parameters are warranted. In this context, multifocal visual evoked potentials (mfVEPs) can make...

    Robert Kolbe, Aykut Aytulun, Ann-Kristin Müller, Marius Ringelstein in BMC Neuroscience (2020)

  12. Article

    Open Access

    Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients

    New-generation cell-based assays have demonstrated a robust association of serum autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-IgG) with (mostly recurrent) optic neuritis, myelit...

    Sven Jarius, Hannah Pellkofer, Nadja Siebert in Journal of Neuroinflammation (2020)

  13. Article

    Open Access

    Retinal layers and visual conductivity changes in a case series of microangiopathic ischemic stroke patients

    It is unknown whether microangiopathic ischemic strokes outside the visual pathway go along with subclinical changes of the retinal structure or the visual system. The objectives of this prospective non-interv...

    John-Ih Lee, Lena Gemerzki, Margit Weise, Laura Boerker, Jonas Graf in BMC Neurology (2020)

  14. Article

    Open Access

    Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients

    New-generation, cell-based assays have demonstrated a robust association of serum autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-IgG) with (mostly recurrent) optic neuritis, myeli...

    Sven Jarius, Christian Lechner, Eva M. Wendel in Journal of Neuroinflammation (2020)

  15. Article

    Erratum zu: Ocrelizumab zur Behandlung der Multiplen Sklerose

    Der Beitrag enthält eine fehlerhafte Tab. 3. Bitte beachten Sie im Folgenden die korrigierte Version der Tabelle. Wir bitten Sie, diese zu beachten und den Fehler zu …

    Jonas Graf, Philipp Albrecht, Norbert Goebels, Orhan Aktas in Der Nervenarzt (2020)

  16. Article

    Open Access

    Ocrelizumab zur Behandlung der Multiplen Sklerose

    Ocrelizumab ist ein monoklonaler Antikörper, der sich gegen das Differenzierungsantigen CD20 richtet und zu einer effektiven längerfristigen Depletion von Lymphozyten, insbesondere von B‑Zellen, führt. Unlängs...

    Jonas Graf, Philipp Albrecht, Norbert Goebels, Orhan Aktas in Der Nervenarzt (2020)

  17. Article

    COVID-19 and management of neuroimmunological disorders

    The importance of reported neurological manifestations of coronavirus disease 2019 (COVID-19) is still unclear. Nevertheless, an immediate and ongoing neurological challenge posed by the COVID-19 pandemic is t...

    Hans-Peter Hartung, Orhan Aktas in Nature Reviews Neurology (2020)

  18. Article

    Open Access

    Cryptococcal meningoencephalitis in an IgG2-deficient patient with multiple sclerosis on fingolimod therapy for more than five years – case report

    Fingolimod (Gilenya®), a first-in-class sphingosine-1-phosphate receptor modulator is approved for the treatment of relapsing-remitting multiple sclerosis. Fingolimod-induced selective immunosuppression leads ...

    Tobias Wienemann, Ann-Kristin Müller, Colin MacKenzie, Carina Bielor in BMC Neurology (2020)

  19. Article

    Open Access

    Meningitis gone viral: description of the echovirus wave 2013 in Germany

    Aseptic meningitis epidemics may pose various health care challenges.

    Jonas Graf, Christian J. Hartmann, Helmar C. Lehmann in BMC Infectious Diseases (2019)

  20. Article

    Open Access

    Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis

    Retinal optical coherence tomography (OCT) is a clinical and research tool in multiple sclerosis, where it has shown significant retinal nerve fiber (RNFL) and ganglion cell (RGC) layer thinning, while postmor...

    Andrés Cruz-Herranz, Michael Dietrich, Alexander M. Hilla in Journal of Neuroinflammation (2019)

previous disabled Page of 3